T lymphocyte-specific activation of Nrf2 protects from AKI

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 2989-3000

  Noel, Sanjeev ^a   Martina, Maria N ^a   Bandapalle, Samatha ^a   Racusen, Lorraine C ^a   Potteti, Haranatha R ^b   Hamad, Abdel R A ^a   Reddy, Sekhar P ^b   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CD11B ANTIGEN; CD69 ANTIGEN; CREATININE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; CYTOSKELETON PROTEIN; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; KEAP1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MESSENGER RNA; NFE2L2 PROTEIN, MOUSE; NQO1 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; EVOKED VISUAL RESPONSE; EXON; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY FUNCTION; LYMPHOCYTOPOIESIS; MONONUCLEAR CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; TH2 CELL; THYMOCYTE; UPREGULATION; ANIMAL; CD4 LYMPHOCYTE COUNT; COMPLICATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ACUTE KIDNEY INJURY; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; ANIMALS; ANTIOXIDANTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOSKELETAL PROTEINS; GENE AMPLIFICATION; GENE EXPRESSION; HEME OXYGENASE-1; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REPERFUSION INJURY; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949920604     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014100978     Document Type: Article

References (55)

1. Clarkson MR, Friedewald JJ, Eustace JA, Rabb H: Acute kidney injury. In: Brenner & Rector's The Kidney, edited by Brenner BM, 8th Ed., Philadelphia, Saunders, Elsevier, 2008, pp 943-986
2. Srisawat N, Kellum JA: Acute kidney injury: Definition, epidemiology, and outcome. Curr Opin Crit Care 17: 548-555, 2011
3. Rewa O, Bagshaw SM: Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 10: 193-207, 2014
4. Jang HR, Ko GJ, Wasowska BA, Rabb H: The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) 87: 859-864, 2009
5. Kinsey GR, Okusa MD: Role of leukocytes in the pathogenesis of acute kidney injury. Crit Care 16: 214, 2012
6. Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron, Exp Nephrol 109: e102-e107, 2008
7. Xiao X, Hu Y, Quirós PM, Wei Q, López-Otín C, Dong Z: OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Am J Physiol Renal Physiol 306: F1318-F1326, 2014
8. Rabb H, Daniels F, O'DonnellM, Haq M, Saba SR, KeaneW, Tang WW: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000
9. BurneMJ, Daniels F, ElGhandour A,Mauiyyedi S, Colvin RB,O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290, 2001
10. Huang Y, Rabb H, Womer KL: Ischemia-reperfusion and immediate T cell responses. Cell Immunol 248: 4-11, 2007
11. Kinsey GR, Okusa MD: Expanding role of T cells in acute kidney injury. Curr Opin Nephrol Hypertens 23: 9-16, 2014
12. Cemerski S, vanMeerwijk JP, Romagnoli P: Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol 33: 2178-2185, 2003
13. Cemerski S, Cantagrel A, Van Meerwijk JP, Romagnoli P: Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem 277: 19585-19593, 2002
14. Kensler TW, Wakabayashi N, Biswal S: Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116, 2007
15. LiuM, GrigoryevDN, CrowMT, HaasM, YamamotoM, Reddy SP, Rabb H: Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int 76: 277-285, 2009
16. Saito H: Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases. Biochem Pharmacol 85: 865-872, 2013
17. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Pérez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM,WeaverWM, Kelso A, Jaenisch R,Wilson CB: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774, 2001
18. Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, Gabrielson E, Biswal S: Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol 42: 524-536, 2010
19. Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P, Reddy SP, RemickD, Biswal S: EnhancingNrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med 184: 928-938, 2011
20. Ascon DB, AsconM, Satpute S, Lopez-Briones S, Racusen L, Colvin RB, SoloskiMJ, Rabb H: Normal mouse kidneys contain activated and CD3 +CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol 84: 1400-1409, 2008
21. Martina MN, Bandapalle S, Rabb H, Hamad AR: Isolation of double negative ab T cells from the kidney. J Vis Exp 16: 1-6, 2014
22. Juvet SC, Zhang L: Double negative regulatory T cells in transplantation and autoimmunity: Recent progress and future directions. J Mol Cell Biol 4: 48-58, 2012
23. Zhang D, Yang W, Degauque N, Tian Y, Mikita A, Zheng XX: New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109: 4071-4079, 2007
24. Rockwell CE, Zhang M, Fields PE, Klaassen CD: Th2 skewing by activation of Nrf2 in CD4(+) T cells. J Immunol 188: 1630-1637, 2012
25. Rockwell CE, Klaassen CD: Inhibition of IFN production by the Nrf2 activators, tBHQ and BHA, in activated murine T cells. FASEB J 22: 1139.4, 2008
26. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H: Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285: F87-F94, 2003
27. Linfert D, Chowdhry T, Rabb H: Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 23: 1-10, 2009
28. Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, Rabb H: Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 69: 233-238, 2006
29. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
30. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD: Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 77: 771-780, 2010
31. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, Crow MT, King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
32. Bestard O, Cruzado JM, Rama I, Torras J, Gom M, Serón D,Moreso F, Gil-Vernet S, Grinyó JM: Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 19: 2020-2026, 2008
33. Dummer CD, Carpio VN, Gonzalves LF, Manfro RC, Veronese FV: FOXP3+ regulatory T cells: From suppression of rejection to induction of renal allograft tolerance. Transpl Immunol 26: 1-10, 2012
34. Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, GriffinMD: Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int 68: 1096-1108, 2005
35. Dong X, Bachman LA, Miller MN, Nath KA, Griffin MD: Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int 74: 1294-1309, 2008
36. Lee S,Huen S, NishioH, Nishio S, LeeHK, Choi BS, RuhrbergC, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
37. Kobayashi E, Suzuki T, Yamamoto M: Roles nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev 2013: 529219, 2013
38. KoGJ, Boo CS, Jo SK, ChoWY, KimHK:Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 23: 842-852, 2008
39. Li L, Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD: Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 122: 3931-3942, 2012
40. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK: Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179-185, 2003
41. Jackson SH,Devadas S, Kwon J, Pinto LA,WilliamsMS: T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827, 2004
42. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA,Wang CR, Schumacker PT, Licht JD, Perlman H, Bryce PJ, Chandel NS: Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38: 225-236, 2013
43. Zhan M, Brooks C, Liu F, Sun L, Dong Z: Mitochondrial dynamics: Regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83: 568-581, 2013
44. Williams MS, Kwon J: T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 37: 1144-1151, 2004
45. Larbi A, Kempf J, Pawelec G: Oxidative stress modulation and T cell activation. Exp Gerontol 42: 852-858, 2007
46. King MR, Ismail AS, Davis LS, Karp DR: Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J Immunol 176: 2765-2772, 2006
47. Sklavos MM, Tse HM, Piganelli JD: Redox modulation inhibits CD8 T cell effector function. Free Radic Biol Med 45: 1477-1486, 2008
48. Frossi B, De Carli M, Piemonte M, Pucillo C: Oxidative microenvironment exerts an opposite regulatory effect on cytokine production by Th1 and Th2 cells. Mol Immunol 45: 58-64, 2008
49. Stępkowski TM, Kruszewski MK: Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 50: 1186-1195, 2011
50. SkopelitiM, Iconomidou VA, Derhovanessian E, Pawelec G, VoelterW, Kalbacher H, Hamodrakas SJ, Tsitsilonis OE: Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner. Mol Immunol 46: 784-792, 2009
51. Ueda H, Fujita R, Yoshida A, Matsunaga H, Ueda M: Identification of prothymosin-alpha1, the necrosis-apoptosis switchmolecule in cortical neuronal cultures. J Cell Biol 176: 853-862, 2007
52. Wu QQ, Wang Y, Senitko M, Meyer C, Wigley WC, Ferguson DA, Grossman E, Chen J, Zhou XJ, Hartono J, Winterberg P, Chen B, Agarwal A, Lu CY: Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARg, and HO-1. Am J Physiol Renal Physiol 300: F1180-F1192, 2011
53. LibyK,HockT,YoreMM,SuhN, PlaceAE, RisingsongR, WilliamsCR,RoyceDB, Honda T, Honda Y, Gribble GW, Hill-Kapturczak N, Agarwal A, SpornMB: The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res 65: 4789-4798, 2005
54. Liu M, Reddy NM, Higbee EM, Potteti HR, Noel S, Racusen L, Kensler TW, Sporn MB, Reddy SP, Rabb H: The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int 85: 134-141, 2014
55. Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H: Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 177: 3380-3387, 2006